Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway

Fig. 2

The effects of triptolide on lipopolysaccharide (LPS)-induced production of pro-inflammatory (a) TNF-α, (b) IL-6 and (c) MCP-1 in human umbilical vein endothelial cells (HUVECs). HUVECs were treated with LPS (1 μg/ml) in the presence or absence of triptolide (25, 50 or 100 nM) for 6 h. The ELISA assay was used to measure the concentrations of pro-inflammatory cytokines and chemokines in the culture medium. Data are expressed as the mean ± standard error of the mean. *p < 0.05 and **p < 0.01, compared with LPS treatment alone. #p < 0.05, compared with the control group

Back to article page